Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minirin in children and adolescents with nocturnal enuresis
NCT01078753Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Jan 2010
- Primary completion
- Sep 2010
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of desmopressin in nocturnal enuresis (NE), sponsored by Ferring Pharmaceuticals. Primary endpoint: Change in the Number of Wet Nights Between Baseline and Treatment Period II at 4 weeks. Started Jan 2010; status: completed.
02
Drugs
desmopressin
03
Conditions
nocturnal enuresis (NE)
Beyond the preview
Go deeper on NCT01078753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01078753.